Logo of Bayer AG at a plant of the German pharmaceutical and chemical maker in Wuppertal FRANKFURT (Reuters) - Germany's drug assessment body said that data provided by Bayer on its precision cancer ...
FRANKFURT (Reuters) - Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence of benefits, in a setback to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results